Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy

IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma

(2013) Marieke L Kuijjer et al.   BMC CANCER

The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma

(2012) Alexander B. Mohseny et al.   EUROPEAN JOURNAL OF CANCER

Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data

(2012) Marieke L. Kuijjer et al.   GENES CHROMOSOMES & CANCER

Molecular pathology and its diagnostic use in bone tumors

(2012) Karoly Szuhai et al.   Cancer Genetics

Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

(2011) Philip J. Stephens et al.   CELL

Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

(2011) E. P. Buddingh et al.   CLINICAL CANCER RESEARCH

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

(2011) Jakob K. Anninga et al.   EUROPEAN JOURNAL OF CANCER

Targeting AMPK in the treatment of malignancies

(2011) Eliza Vakana et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

(2011) Sant P. Chawla et al.   JOURNAL OF CLINICAL ONCOLOGY

Cyclin E1 Is Amplified and Overexpressed in Osteosarcoma

(2011) William W. Lockwood et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Functional characterization of osteosarcoma cell lines provides representative models to study the human disease

(2011) Alexander B Mohseny et al.   LABORATORY INVESTIGATION

Testing of the Akt/PKB inhibitor MK-2206 by the pediatric preclinical testing program

(2011) Richard Gorlick et al.   PEDIATRIC BLOOD & CANCER

Targets for cancer therapy in childhood sarcomas

(2010) Marco Wachtel et al.   CANCER TREATMENT REVIEWS

Emerging drugs for high-grade osteosarcoma

(2010) Claudia Maria Hattinger et al.   EXPERT OPINION ON EMERGING DRUGS

Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma

(2010) Alexander B. Mohseny et al.   GENES CHROMOSOMES & CANCER

Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option

(2010) Stefan M Willems et al.   Molecular Cancer

Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program

(2010) E. Anders Kolb et al.   PEDIATRIC BLOOD & CANCER

Erratum: Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways

(2009) A-M Cleton-Jansen et al.   BRITISH JOURNAL OF CANCER

Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment

(2009) Y. M. Schrage et al.   CANCER RESEARCH

Akt-dependent and -independent mechanisms of mTOR regulation in cancer

(2009) Regan M. Memmott et al.   CELLULAR SIGNALLING

Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort

(2009) Laura Ottaviano et al.   GENES CHROMOSOMES & CANCER

arrayQualityMetrics—a bioconductor package for quality assessment of microarray data

(2008) Audrey Kauffmann et al.   BIOINFORMATICS